When and How to Evaluate Vitamin D Status? A Viewpoint from the Belgian Bone Club

Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study

Menopause Hormone Therapy in the Management of Postmenopausal Osteoporosis

Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee Cohort

Menopausal hormone therapy and breast cancer risk

The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

How to manage osteoporosis before the age of 50

Osteoporosis treatment gap in a prospective cohort of volunteer women

Underevaluation of fractures by self-report: an analysis from the FRISBEE cohort

Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4)

Attitudes to the prescription of menopause hormone therapy for vasomotor symptoms and osteoporosis for patients of different ages: A survey of gynecologists in Belgium

[La ménopause et le traitement hormonal de la ménopause : une actualisation]

Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studies

Skeletal health in breast cancer survivors

Should we abstain from treating women with endometriosis using menopausal hormone therapy, for fear of an increased ovarian cancer risk?

Charcot spine and Parkinson's disease

Postmenopausal hormone therapy: risks and benefits

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

Health technology assessment in osteoporosis

EMAS position statement: Vitamin D and postmenopausal health

Recommendations on the management of fragility fracture risk in women younger than 70 years

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis

Entering functional restoration programs for chronic low back pain is delayed when patients do not receive support at work: A study of 185 patients in France

A national media mass campaign improves beliefs and behaviours about low back pain in the general population and in general practitioners

Clinical guidelines and care pathway for management of low back pain with or without radicular pain

Development and validation of a questionnaire categorizing behavioral strategies in patients with chronic low back pain

Functional restoration programs in patients with chronic low back pain and body composition: No change in muscle mass assessed through Dual X-ray absorptiometry in 94 patients, a monocenter longitudinal study

The impact of chronic low back pain is partly related to loss of social role: A qualitative study

Relationship between optimism and quality of life in patients with two chronic rheumatic diseases: axial spondyloarthritis and chronic low back pain: a cross sectional study of 288 patients

Validity of the French version of the Core Outcome Measures Index for low back pain patients: a prospective cohort study

Treatment strategy for chronic low back pain

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study

Reliability and validity of the cross-culturally adapted French version of the Core Outcome Measures Index (COMI) in patients with low back pain

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club

The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club

How to assess breast cancer risk in menopausal patients being treated with menopausal hormone therapy?

Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia

Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

Epidural corticosteroid injections: Still credible?

Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: A substudy of the FRISBEE cohort

MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® Score

Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity

Effects of Dairy Products Consumption on Health: Benefits and Beliefs--A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy

Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120)

Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity

Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs

Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis